Chronic obstructive pulmonary disease (COPD)
612 results
1 - 100
Chronic obstructive pulmonary disease (COPD) - Chronic obstructive pulmonary disease (COPD) - Audio
Tai Chi for chronic obstructive pulmonary disease (COPD)- Influenza vaccine for chronic obstructive pulmonary disease (COPD)
- Cognitive behavioural approaches for managing dyspnoea in people with chronic obstructive pulmonary disease (COPD)
- Interventions for sexual dysfunction in people with chronic obstructive pulmonary disease (COPD)
- Prophylactic antibiotic therapy for chronic obstructive pulmonary disease (COPD)
- Interventions for promoting physical activity in people with chronic obstructive pulmonary disease (COPD)
- Umeclidinium bromide versus placebo for people with chronic obstructive pulmonary disease (COPD)
- Interventions to improve adherence to pharmacological therapy for chronic obstructive pulmonary disease (COPD)
- Telehealth interventions: remote monitoring and consultations for people with chronic obstructive pulmonary disease (COPD)
- Combined aclidinium bromide and long‐acting beta2‐agonist for chronic obstructive pulmonary disease (COPD)
- Inspiratory muscle training, with or without concomitant pulmonary rehabilitation, for chronic obstructive pulmonary disease (COPD)
- Dual combination therapy versus long‐acting bronchodilators alone for chronic obstructive pulmonary disease (COPD): a systematic review and network meta‐analysis
- Antibiotics for exacerbations of chronic obstructive pulmonary disease
- Pulmonary rehabilitation for chronic obstructive pulmonary disease
- Nutritional supplementation for stable chronic obstructive pulmonary disease: Cochrane systematic review
Gabapentinoids are associated with severe exacerbations of chronic obstructive pulmonary disease- Oral corticosteroids for stable chronic obstructive pulmonary disease
- Oral theophylline for chronic obstructive pulmonary disease
- Prolonged cough in adults
- Prophylactic antibiotic therapy for chronic obstructive pulmonary disease
- Influenza vaccine for patients with chronic obstructive pulmonary disease
- Anticholinergic bronchodilators versus beta2‐sympathomimetic agents for acute exacerbations of chronic obstructive pulmonary disease
- Cardioselective beta‐blockers for chronic obstructive pulmonary disease
- Combination inhaled steroid and long-acting beta2-agonist versus tiotropium for chronic obstructive pulmonary disease: Cochrane systematic review
- Statins versus placebo for people with chronic obstructive pulmonary disease: Cochrane systematic review
- Ipratropium bromide versus short acting beta‐2 agonists for stable chronic obstructive pulmonary disease
- Heliox for treatment of exacerbations of chronic obstructive pulmonary disease
- Inhaled corticosteroids in COPD
- Pressurised metered‐dose inhalers versus all other hand‐held inhalers devices to deliver bronchodilators for chronic obstructive pulmonary disease
- Short‐term ambulatory oxygen for chronic obstructive pulmonary disease
- Airway clearance techniques for chronic obstructive pulmonary disease
- USPSTF 2022: Recommendation against screening for chronic obstructive pulmonary disease (D recommendation)
- Pulmonary rehabilitation after hospitalization for chronic obstructive pulmonary disease improves mortality
- Domiciliary oxygen for chronic obstructive pulmonary disease
- Anticholinergics for maintenance treatment of stable COPD
- Pneumococcal vaccines for preventing pneumonia in chronic obstructive pulmonary disease
- Long-acting beta2-agonists for poorly reversible chronic obstructive pulmonary disease: Cochrane systematic review
- Inhaled corticosteroids versus long‐acting beta2‐agonists for chronic obstructive pulmonary disease
- Carbonic anhydrase inhibitors for hypercapnic ventilatory failure in chronic obstructive pulmonary disease
- Breathing exercises for chronic obstructive pulmonary disease: Cochrane systematic review
- Home care by outreach nursing for chronic obstructive pulmonary disease
- Ipratropium bromide versus long-acting beta-2 agonists for stable chronic obstructive pulmonary disease: Cochrane systematic review
- Short‐acting beta2‐agonists for stable chronic obstructive pulmonary disease
- The effect of adding inhaled corticosteroids to tiotropium and long-acting beta 2 -agonists for chronic obstructive pulmonary disease: Cochrane systematic review
- Summary of GOLD guideline for COPD
- Canadian Thoracic Society guidelines for pharmacotherapy of stable chronic obstructive pulmonary disease
- Bisoprolol does not reduce exacerbations in adults with chronic obstructive pulmonary disease (BICS)
- Integrated disease management interventions for patients with chronic obstructive pulmonary disease
- Tiotropium for stable chronic obstructive pulmonary disease
- Improved outcomes with azithromycin vs beta-lactams for acute exacerbations of chronic obstructive pulmonary disease
- In high-risk patients with chronic obstructive pulmonary disease, dupilumab slightly reduces moderate exacerbation (BOREAS)